Pfizer to Ask for Approval of COVID-19 Vaccine for Children 12–15-US News | The Epoch Times

Pfizer and its German partner on Monday said they plan to file for expanded approval from U.S. regulators for their COVID-19 vaccine after a new study indicated the shot remains effective for over four months. Vaccinated children 12 to 15 saw 100 percent effectiveness against COVID-19 in an ongoing clinical trial, Pfizer and BioNTech said in a statement. That conclusion was drawn from measurements taken seven days through over four months after the second dose of the two-dose regimen. Data from 2,228 participants were analyzed. Thirty COVID-19 cases were detected but all 30 patients received a placebo, not the vaccine, according to the companies. The data have not been peer-reviewed and much of it has not been made public. There are plans to submit them for scientific peer review “for potential publication,” Pfizer and BioNTech said. The companies also said the safety data was “generally consistent” with other safety data …

Zachary Stieber

Leave a Reply

Your email address will not be published.

Next Post

Next Manchester United manager: Updates on Pochettino, Zidane, Rodgers & others-Sporting News

Mon Nov 22 , 2021
There are plenty of developments in the pursuit to fill the permanent manager role at Manchester United with Mauricio Pochettino gaining steam. There are plenty of developments in the pursuit to fill the permanent manager role at Manchester United with Mauricio Pochettino gaining steam.   

Newsletter Signup

Sign up now and never miss a thing!

You're Signed Up!

Now that you are signed up, we will send you exclusive offers periodically.